DK1077688T3 - Transdermalt terapeutisk syestem (TTS) indeholdende pergolid - Google Patents

Transdermalt terapeutisk syestem (TTS) indeholdende pergolid

Info

Publication number
DK1077688T3
DK1077688T3 DK99923585T DK99923585T DK1077688T3 DK 1077688 T3 DK1077688 T3 DK 1077688T3 DK 99923585 T DK99923585 T DK 99923585T DK 99923585 T DK99923585 T DK 99923585T DK 1077688 T3 DK1077688 T3 DK 1077688T3
Authority
DK
Denmark
Prior art keywords
tts
pergolide
meth
therapeutic system
transdermal therapeutic
Prior art date
Application number
DK99923585T
Other languages
Danish (da)
English (en)
Inventor
Christoph Arth
Andreas Kollmeyer-Seeger
Stephan Rimpler
Hans-Michael Wolff
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Application granted granted Critical
Publication of DK1077688T3 publication Critical patent/DK1077688T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK99923585T 1998-05-15 1999-05-12 Transdermalt terapeutisk syestem (TTS) indeholdende pergolid DK1077688T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19821788A DE19821788C1 (de) 1998-05-15 1998-05-15 Transdermales Therapeutisches System (TTS) Pergolid enthaltend
PCT/EP1999/003278 WO1999059558A1 (de) 1998-05-15 1999-05-12 Transdermales therapeutisches system (tts) pergolid enthaltend

Publications (1)

Publication Number Publication Date
DK1077688T3 true DK1077688T3 (da) 2002-04-02

Family

ID=7867847

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99923585T DK1077688T3 (da) 1998-05-15 1999-05-12 Transdermalt terapeutisk syestem (TTS) indeholdende pergolid

Country Status (20)

Country Link
US (1) US6461636B1 (pt)
EP (1) EP1077688B1 (pt)
JP (1) JP4556039B2 (pt)
KR (1) KR100507266B1 (pt)
CN (1) CN1190189C (pt)
AT (1) ATE210432T1 (pt)
AU (1) AU743229C (pt)
BR (1) BR9910404B1 (pt)
CA (1) CA2327187C (pt)
DE (2) DE19821788C1 (pt)
DK (1) DK1077688T3 (pt)
ES (1) ES2167116T3 (pt)
HK (1) HK1037541A1 (pt)
IL (1) IL138005A (pt)
MX (1) MXPA00011253A (pt)
NO (1) NO329042B1 (pt)
PL (1) PL192213B1 (pt)
PT (1) PT1077688E (pt)
WO (1) WO1999059558A1 (pt)
ZA (1) ZA200004670B (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
DE10033855A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Matrixkontrolliertes transdermales System mit Sulfonsäuresalz eines ACE-Hemmers
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
DE10341317B4 (de) * 2003-09-03 2008-10-23 Axxonis Pharma Ag Transdermales therapeutisches System (TTS) zur Verabreichung von Ergolinverbindungen ausgenommen Pergolid
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
EP1366762B1 (en) * 2001-03-07 2015-12-30 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
DE60233217D1 (de) 2001-05-01 2009-09-17 Corium Internat Inc Hydrogel-zusammensetzungen
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
CA2447302C (en) 2001-05-01 2008-07-29 A.V. Topchiev Institute Of Petrochemical Synthesis Two-phase, water-absorbent bioadhesive composition
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
DE10234673B4 (de) 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
JP4792193B2 (ja) * 2002-08-28 2011-10-12 久光製薬株式会社 貼付剤
JP4213432B2 (ja) * 2002-08-28 2009-01-21 久光製薬株式会社 貼付剤
DE10252863B4 (de) 2002-11-12 2007-04-19 Kronotec Ag Holzfaserplatte, insbesondere Fussbodenpaneel
US7617651B2 (en) 2002-11-12 2009-11-17 Kronotec Ag Floor panel
ES2307840T3 (es) 2002-11-15 2008-12-01 Flooring Technologies Ltd. Equipo compuesto por dos placas de construccion que pueden unirse entre si y una pieza insertada para enclavar estas placas de construccion.
DE10306118A1 (de) 2003-02-14 2004-09-09 Kronotec Ag Bauplatte
US7678425B2 (en) 2003-03-06 2010-03-16 Flooring Technologies Ltd. Process for finishing a wooden board and wooden board produced by the process
DE20304761U1 (de) 2003-03-24 2004-04-08 Kronotec Ag Einrichtung zum Verbinden von Bauplatten, insbesondere Bodenpaneele
DE10362218B4 (de) 2003-09-06 2010-09-16 Kronotec Ag Verfahren zum Versiegeln einer Bauplatte
DE20315676U1 (de) 2003-10-11 2003-12-11 Kronotec Ag Paneel, insbesondere Bodenpaneel
TW200514582A (en) * 2003-10-31 2005-05-01 Hisamitsu Pharmaceutical Co Transdermal preparation and method for reducing side effect in pergolide therapy
CA2554649C (en) 2004-01-30 2015-10-27 Corium International, Inc. Rapidly dissolving film for delivery of an active agent
US20070190123A1 (en) * 2004-01-30 2007-08-16 Kazunosuke Aida Cover material and plaster with cover material
DE102004011931B4 (de) 2004-03-11 2006-09-14 Kronotec Ag Dämmstoffplatte aus einem Holzwerkstoff-Bindemittelfaser-Gemisch
WO2005115355A1 (ja) * 2004-05-28 2005-12-08 Hisamitsu Pharmaceutical Co., Inc. 貼付製剤
ES2526700T3 (es) 2004-08-05 2015-01-14 Corium International, Inc. Composición de adhesivo
AU2006209239A1 (en) * 2005-01-27 2006-08-03 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrophilic biocompatible adhesive formulations and uses
WO2006082728A1 (ja) * 2005-02-04 2006-08-10 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収貼付剤
DE102005042658B3 (de) 2005-09-08 2007-03-01 Kronotec Ag Bauplatte, insbesondere Fußbodenpaneel
DE102005042657B4 (de) 2005-09-08 2010-12-30 Kronotec Ag Bauplatte und Verfahren zur Herstellung
US7854986B2 (en) 2005-09-08 2010-12-21 Flooring Technologies Ltd. Building board and method for production
DE102005063034B4 (de) 2005-12-29 2007-10-31 Flooring Technologies Ltd. Paneel, insbesondere Bodenpaneel
DE102006007976B4 (de) 2006-02-21 2007-11-08 Flooring Technologies Ltd. Verfahren zur Veredelung einer Bauplatte
CA2751884C (en) 2009-01-14 2018-09-25 Corium International, Inc. Transdermal administration of tamsulosin
NZ725354A (en) 2014-06-18 2018-05-25 Elanco Us Inc Transdermal formulations of pergolide and uses thereof
WO2016038629A1 (en) 2014-09-10 2016-03-17 Council Of Scientific & Industrial Research A single step process for the preparation of butyl acetate
TWI741168B (zh) * 2017-04-28 2021-10-01 日商日東電工股份有限公司 經皮吸收製劑

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
US6572879B1 (en) * 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
DE19626621A1 (de) * 1996-07-02 1998-01-08 Hexal Ag Pflaster zur transdermalen Anwendung von Pergolid
CA2259353C (en) * 1996-07-02 2006-09-05 Hexal Ag Plaster for the transdermal application of pergolide
DE19728517C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
CN1301152A (zh) 2001-06-27
DE59900548D1 (de) 2002-01-24
AU4040799A (en) 1999-12-06
ZA200004670B (en) 2000-11-22
JP2002515424A (ja) 2002-05-28
NO20004859D0 (no) 2000-09-27
EP1077688B1 (de) 2001-12-12
ES2167116T3 (es) 2002-05-01
EP1077688A1 (de) 2001-02-28
PT1077688E (pt) 2002-05-31
IL138005A (en) 2005-07-25
PL192213B1 (pl) 2006-09-29
KR20010042685A (ko) 2001-05-25
WO1999059558A1 (de) 1999-11-25
US6461636B1 (en) 2002-10-08
DE19821788C1 (de) 1999-12-02
CN1190189C (zh) 2005-02-23
IL138005A0 (en) 2001-10-31
NO329042B1 (no) 2010-08-02
PL344160A1 (en) 2001-10-08
NO20004859L (no) 2000-09-27
CA2327187A1 (en) 1999-11-25
HK1037541A1 (en) 2002-02-15
BR9910404B1 (pt) 2009-12-01
MXPA00011253A (es) 2003-05-19
AU743229B2 (en) 2002-01-24
ATE210432T1 (de) 2001-12-15
BR9910404A (pt) 2001-01-09
CA2327187C (en) 2005-12-27
KR100507266B1 (ko) 2005-08-10
AU743229C (en) 2003-03-20
JP4556039B2 (ja) 2010-10-06

Similar Documents

Publication Publication Date Title
DE59900548D1 (de) Transdermales therapeutisches system (tts) pergolid enthaltend
DK1178782T3 (da) Transdermalt terapeutisk system (TTS) indeholdende tolterodin
FI95775C (fi) Menetelmä transdermaalisen terapeuttisen systeemin valmistamiseksi fysostigmiinin annostelemiseksi iholle
CA2153572A1 (en) Transdermal therapeutic system with galanthamine as active ingredient
SE9503924D0 (sv) Novel opioid peptides
DE59807891D1 (de) Transdermales therapeutisches system (tts) enthaltend ammoniogruppenhaltige (meth)acrylatpolymere zur verabreichung von levonorgestrel
DE59900497D1 (de) Transdermales therapeutisches system (tts) oxybutynin enthaltend
DK1355636T3 (da) Transdermalt terapeutisk system til administrering af carboxylgruppeholdige, ikke-steroidale antiflogistika samt en fremgangsmåde til fremstilling deraf
DK1303278T3 (da) Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme
MD937C2 (ro) Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui
HUP9904578A2 (hu) Xanomelin alkalmazása bipoláris depresszió kezelésére szolgáló gyógyszerkészítmények előállítására
ATE252895T1 (de) Transdermales therapeutisches system und verfahren zu seiner herstellung
MD348C2 (ro) Sistem terapeutic transdermal şi procedeu de obţinere a acestuia
DE69803607D1 (de) Zusammensetzungen zur transdermalen und dermalen verabreichung von biologisch wirksamen stoffen
SE9502877D0 (sv) Novel opioid peptides